Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology

被引:27
|
作者
Zehbe, Ingeborg [1 ,2 ,3 ]
Jackson, Robert [1 ,4 ]
Wood, Brianne [5 ]
Weaver, Bruce [3 ]
Escott, Nicholas [3 ,6 ]
Severini, Alberto [7 ]
Krajden, Mel [8 ]
Bishop, Lisa [2 ]
Morrisseau, Kyla [2 ]
Ogilvie, Gina [8 ,9 ]
Burchell, Ann N. [10 ,11 ]
Little, Julian [5 ]
机构
[1] Thunder Bay Reg Res Inst, Probe Dev & Biomarker Explorat, Thunder Bay, ON, Canada
[2] Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada
[3] Northern Ontario Sch Med, Clin Sci, Thunder Bay, ON, Canada
[4] Lakehead Univ, Biotechnol Program, Thunder Bay, ON, Canada
[5] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[6] Thunder Bay Reg Hlth Sci Ctr, Dept Pathol & Lab Med, Thunder Bay, ON, Canada
[7] Publ Hlth Agcy Canada, Viral Exanthemata & STD Sect, Natl Microbiol Lab, Winnipeg, MB, Canada
[8] BC Ctr Dis Control, Vancouver, BC, Canada
[9] Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada
[10] Ontario HIV Treatment Network, Toronto, ON, Canada
[11] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源
BMJ OPEN | 2016年 / 6卷 / 10期
基金
加拿大健康研究院;
关键词
TO-TREAT ANALYSIS; 1ST NATIONS; NEW-ZEALAND; WOMEN; HPV; STATEMENT; CANADA; INTERVENTION; INDIVIDUALS; AUSTRALIA;
D O I
10.1136/bmjopen-2016-011754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The incidence of cervical cancer is up to 20-fold higher among First Nations women in Canada than the general population, probably due to lower participation in screening. Offering human papillomavirus (HPV) self-sampling in place of Papanicolaou (Pap) testing may eventually increase screening participation and reduce cervical cancer rates in this population. Design: A community-randomised controlled screening trial. Setting: First Nations communities in Northwest Ontario, Canada. Participants: Women aged between 25 and 69, living in Robinson Superior Treaty First Nations. The community was the unit of randomisation. Interventions: Women were asked to complete a questionnaire and have screening by HPV self-sampling (arm A) or Pap testing (arm B). Primary outcome measures: The number of women who participated in cervical screening. Randomisation: Community clusters were randomised to include approximately equivalent numbers of women in each arm. Results: 6 communities were randomised to arm A and 5 to arm B. One community withdrew, leaving 5 communities in each group (834 eligible women). Participation was <25%. Using clustered intention-to-treat (ITT) analysis, initial and cumulative averaged uptakes in arm A were 1.4-fold (20% vs 14.3%, p=0.628) and 1.3-fold (20.6% vs 16%, p=0.694) higher compared to arm B, respectively. Corresponding per protocol (PP) analysis indicates 2.2-fold (22.9% vs 10.6%, p=0.305) and 1.6-fold (22.9% vs 14.1%, p=0.448) higher uptakes in arm A compared to arm B. Screening uptake varied between communities (range 0-62.1%). Among women who completed a questionnaire (18.3% in arm A, 21.7% in arm B), the screening uptake was 1.8-fold (ITT; p=0.1132) or 3-fold (PP; p<0.01) higher in arm A versus arm B. Conclusions: Pap and HPV self-sampling were compared in a marginalised, Canadian population. Results indicated a preference for self-sampling. More research on how to reach underscreened Indigenous women is necessary.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Self-sampling to improve cervical cancer screening coverage in Switzerland: a randomised controlled trial
    Manuela Viviano
    Rosa Catarino
    Emilien Jeannot
    Michel Boulvain
    Manuela Undurraga Malinverno
    Pierre Vassilakos
    Patrick Petignat
    British Journal of Cancer, 2017, 116 : 1382 - 1388
  • [2] Self-sampling to improve cervical cancer screening coverage in Switzerland: a randomised controlled trial
    Viviano, Manuela
    Catarino, Rosa
    Jeannot, Emilien
    Boulvain, Michel
    Malinverno, Manuela Undurraga
    Vassilakos, Pierre
    Petignat, Patrick
    BRITISH JOURNAL OF CANCER, 2017, 116 (11) : 1382 - 1388
  • [3] Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening
    Liebermann, Erica
    Fontenot, Holly B.
    Lim, Eunjung
    Matsunaga, Masako
    Zimet, Gregory
    Allen, Jennifer D.
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2023, 52 (05): : 364 - 373
  • [4] Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening
    Lefeuvre, Caroline
    De Pauw, Helene
    Le Duc Banaszuk, Anne-Sophie
    Pivert, Adeline
    Ducancelle, Alexandra
    Rexand-Galais, Franck
    Arbyn, Marc
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2022, 67
  • [5] Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection
    Fujita, Misuzu
    Shimazu, Minobu
    Nagashima, Kengo
    Suzuki, Misae
    Tauchi, Ichiro
    Sakuma, Miwa
    Yamamoto, Setsuko
    Shozu, Makio
    Hanaoka, Hideki
    Tsuruoka, Nobuhide
    Kasai, Tokuzo
    Hata, Akira
    BMJ OPEN, 2022, 12 (02):
  • [6] Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening
    Chatzistamatiou, Kimon
    Vrekoussis, Thomas
    Tsertanidou, Athena
    Moysiadis, Theodoros
    Mouchtaropoulou, Evangelia
    Pasentsis, Konstantinos
    Kitsou, Anastasia
    Moschaki, Viktoria
    Ntoula, Maria
    Zempili, Paraskevi
    Halatsi, Despina
    Truva, Theoni
    Piha, Vaia
    Agelena, Georgia
    Daponte, Alexandros
    Vanakara, Polyxeni
    Paschopoulos, Minas
    Stefos, Theodoros
    Lymberis, Vasilis
    Kontomanolis, Emmanuel N.
    Makrigiannakis, Antonis
    Deligeoroglou, Efthimios
    Panoskaltsis, Theodoros
    Adonakis, George
    Michail, George
    Stamatopoulos, Kostas
    Agorastos, Theodoros
    JOURNAL OF WOMENS HEALTH, 2020, 29 (11) : 1447 - 1456
  • [7] Shanxi Province cervical cancer screening study II: Self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology
    Belinson, JL
    Qiao, YL
    Pretorius, RG
    Zhang, WH
    Rong, SD
    Huang, MN
    Zhao, FH
    Wu, LY
    Ren, SD
    Huang, RD
    Washington, MF
    Pan, QJ
    Li, L
    Fife, D
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (06) : 819 - 826
  • [8] Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening
    Wong, Eliza L. Y.
    Chan, Paul K. S.
    Chor, Josette S. Y.
    Cheung, Annie W. L.
    Huang, Fenwei
    Wong, Samuel Y. S.
    CANCER NURSING, 2016, 39 (01) : E1 - E11
  • [9] A Randomized Trial of Human Papillomavirus Self-Sampling as an Intervention to Promote Cervical Cancer Screening Among Women With HIV
    Murphy, Jeanne
    Mark, Hayley
    Anderson, Jean
    Farley, Jason
    Allen, Jerilyn
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2016, 20 (02) : 139 - 144
  • [10] Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial
    Winer, Rachel L.
    Lin, John
    Anderson, Melissa L.
    Tiro, Jasmin A.
    Green, Beverly B.
    Gao, Hongyuan
    Meenan, Richard T.
    Hansen, Kristina
    Sparks, Angela
    Buist, Diana S. M.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2024, 79 (03) : 161 - 162